# concordance
Concordancia clínico-patológica en 1056 casos de biopsias cutáneas. Experiencia en un centro terciario

|**Characteristic**                            |**No**, N = 278 |**Si**, N = 765 |**p-value** |**Overall**, N = 1,043 | |:---------------------------------------------|:---------------|:---------------|:-----------|:----------------------| |Type                                          |NA              |NA              |NA          |NA                     | |Dermatosis inflamatorias                      |8 (2.9%)        |23 (3.0%)       |NA          |31 (3.0%)              | |Efectos cutáneos adversos de los medicamentos |0 (0%)          |7 (0.9%)        |NA          |7 (0.7%)               | |Enfermedades de las estructuras anexiales     |10 (3.6%)       |12 (1.6%)       |NA          |22 (2.1%)              | |Enfermedades del tejido conjuntivo            |3 (1.1%)        |11 (1.4%)       |NA          |14 (1.3%)              | |Enfermedades infecciosas                      |5 (1.8%)        |18 (2.4%)       |NA          |23 (2.2%)              | |Enfermedades pigmentarias                     |0 (0%)          |3 (0.4%)        |NA          |3 (0.3%)               | |Enfermedades vasculares                       |4 (1.4%)        |24 (3.1%)       |NA          |28 (2.7%)              | |Enfermedades vesiculobullosas                 |1 (0.4%)        |5 (0.7%)        |NA          |6 (0.6%)               | |Granuloma no infeccioso                       |4 (1.4%)        |7 (0.9%)        |NA          |11 (1.1%)              | |Neoplasia                                     |227 (82%)       |586 (77%)       |NA          |813 (78%)              | |Otros                                         |4 (1.4%)        |19 (2.5%)       |NA          |23 (2.2%)              | |Paniculitis                                   |0 (0%)          |1 (0.1%)        |NA          |1 (<0.1%)              | |Quiste                                        |11 (4.0%)       |45 (5.9%)       |NA          |56 (5.4%)              | |Vasculitis cutáneas                           |1 (0.4%)        |4 (0.5%)        |NA          |5 (0.5%)               | |Sexo                                          |NA              |NA              |0.4         |NA                     | |F                                             |150 (56%)       |397 (53%)       |NA          |547 (54%)              | |M                                             |119 (44%)       |354 (47%)       |NA          |473 (46%)              | |Unknown                                       |9               |14              |NA          |23                     | |Edad                                          |51 (41, 64)     |49 (38, 64)     |0.3         |50 (39, 64)            | |Unknown                                       |9               |16              |NA          |25                     | |Tipo                                          |NA              |NA              |0.6         |NA                     | |Ampliacion                                    |1 (0.4%)        |4 (0.5%)        |NA          |5 (0.5%)               | |Escisional                                    |202 (73%)       |539 (71%)       |NA          |741 (71%)              | |Incisional                                    |48 (17%)        |159 (21%)       |NA          |207 (20%)              | |Punch                                         |26 (9.4%)       |61 (8.0%)       |NA          |87 (8.4%)              | |Unknown                                       |1               |2               |NA          |3                      | |Sitio                                         |NA              |NA              |0.038       |NA                     | |Cabeza                                        |84 (32%)        |305 (41%)       |NA          |389 (39%)              | |Extremidad inferior                           |47 (18%)        |92 (12%)        |NA          |139 (14%)              | |Extremidad superior                           |32 (12%)        |69 (9.3%)       |NA          |101 (10%)              | |Genital                                       |6 (2.3%)        |11 (1.5%)       |NA          |17 (1.7%)              | |Tronco                                        |95 (36%)        |263 (35%)       |NA          |358 (36%)              | |Uña                                           |1 (0.4%)        |2 (0.3%)        |NA          |3 (0.3%)               | |Unknown                                       |13              |23              |NA          |36                     |
